Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 18, 2023 07:00 ET | Source: Acelyrin, Inc.

ACELYRIN, INC. Appoints Ken Lock as Chief Commercial Officer

Accomplished global leader brings 20 years of immunology sales and marketing expertise. ACEYLRIN currently has a robust portfolio including late-stage clinical trials underway supporting multiple...
June 15, 2023 16:05 ET | Source: Acelyrin, Inc.

ACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights

Initial Public Offering generated gross proceeds of $621 million; net proceeds of $573.7 million– Strong cash position of $289.2 million at end of Q1 2023– $862.9 million from IPO net proceeds and...